investor losses

Rosen Law Firm investigates Hitek Global ($HKIT) over alleged materially misleading disclosures; shareholders encouraged to join potential class action lawsuit to recover losses.

Freshpet stock fell 11% after regulators ruled its 'human-grade' pet food claims misleading. Securities litigation firm investigating potential investor losses.

Class action lawsuit filed against $ORCL alleging concealment of massive AI infrastructure costs. Stock fell 15% after December disclosure of $35.5B capex and $248B lease commitments.

Disc Medicine ($IRON) stock fell 22% after FDA rejected bitopertin program, triggering class action lawsuit investigation by Rosen Law Firm.

$PSIX faces securities fraud lawsuit alleging overstated data center demand and understated manufacturing costs between May 2025-March 2026. Shareholders can join by May 19, 2026.

Elauwit Connection restates financials due to revenue recognition errors; stock drops 6.8%. Class action investigation underway for investor losses.

TruBridge restates three years of financials due to material errors in revenue recognition, stock-based compensation, and software capitalization. Stock fell 10.5%.

Class action lawsuit filed against $LU over alleged material misstatements and inadequate internal controls spanning 2022-2023, triggering 13.8% stock decline.

Class action lawsuit filed against Coty over alleged misstatements on beauty market performance, margin compression, and segment growth between November 2025 and February 2026. Lead plaintiff deadline: May 22, 2026.

The Portnoy Law Firm investigates $TNDM after a 19.9% stock plunge triggered by insulin pump malfunction disclosures that could halt insulin delivery.

Johnson Fistel investigates Lumexa Imaging Holdings for potential securities fraud following March 2026 disclosures that triggered significant stock declines. Affected investors are encouraged to contact the firm about recovery options.

Class action lawsuit filed against $PSIX alleging false statements about data center sales capture and understated manufacturing costs. Investor deadline set for May 19, 2026.

Law firm sues Franklin BSP Realty Trust ($FBRT) for allegedly overstating prospects and dividend sustainability. Investors can join as lead plaintiffs by April 27, 2026.

Four public companies face securities fraud class actions alleging misrepresentations in operational performance, clinical trials, and financial reporting. Lead plaintiff deadlines: May 5-8, 2026.

Law firm investigates JFrog for possible securities fraud after 27.5% stock decline triggered by slashed guidance and weak cloud revenue growth.

Portnoy Law Firm sues Soleno Therapeutics for allegedly concealing DCCR safety risks in Phase 3 trials, citing 27% stock drop on November 4, 2025.

Portnoy Law Firm files class action lawsuit against Boston Scientific for allegedly misleading investors about growth prospects and competitive pressures in electrophysiology market.

Portnoy Law Firm files class action against Aquestive Therapeutics for allegedly failing to disclose FDA deficiencies in Anaphylm NDA, causing 37% stock decline.

Rosen Law Firm investigates $CHSN for allegedly issuing materially misleading business information, preparing class action lawsuit to recover investor losses.

Aldeyra Therapeutics plummets 71% after FDA rejects lead dry eye drug. Securities litigation firm investigating potential investor claims following efficacy concerns.